Ciprofloxacin sensitizes hormone-refractory prostate cancer cell lines to doxorubicin and docetaxel treatment on a schedule-dependent manner

Authors

Keywords

Journal

Volume 64, Issue 3, Pages 445-454

Publisher

Springer Nature

Online

2008-12-23

DOI

10.1007/s00280-008-0892-6

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started